| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ernexa Therapeutics Inc. (ERNAW) has 1 insider with recent SEC Form 4 filings, including 1 buy and 0 sells.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 6.78M | $393.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | Cherington Charles46 | 10% Owner | Buy | 4,000,000 | $0.50 | $2,000,000.00 | +143.9% | - | - |